- Home
- NEU vs IONS Comparison
NEU vs IONS Comparison
Compare NEU & IONS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEU
- IONS
- Stock Information
- Founded
- NEU 1887
- IONS 1989
- Country
- NEU United States
- IONS United States
- Employees
- NEU N/A
- IONS N/A
- Industry
- NEU Major Chemicals
- IONS Biotechnology: Pharmaceutical Preparations
- Sector
- NEU Industrials
- IONS Health Care
- Exchange
- NEU Nasdaq
- IONS Nasdaq
- Market Cap
- NEU 5.4B
- IONS 4.6B
- IPO Year
- NEU N/A
- IONS 1991
- Fundamental
- Price
- NEU $633.08
- IONS $32.26
- Analyst Decision
- NEU
- IONS Buy
- Analyst Count
- NEU 0
- IONS 18
- Target Price
- NEU N/A
- IONS $57.41
- AVG Volume (30 Days)
- NEU 36.9K
- IONS 1.7M
- Earning Date
- NEU 04-23-2025
- IONS 04-30-2025
- Dividend Yield
- NEU 1.74%
- IONS N/A
- EPS Growth
- NEU 20.83
- IONS N/A
- EPS
- NEU 50.24
- IONS N/A
- Revenue
- NEU $2,790,768,000.00
- IONS $717,253,000.00
- Revenue This Year
- NEU N/A
- IONS N/A
- Revenue Next Year
- NEU N/A
- IONS $27.39
- P/E Ratio
- NEU $12.61
- IONS N/A
- Revenue Growth
- NEU 3.65
- IONS N/A
- 52 Week Low
- NEU $480.00
- IONS $23.95
- 52 Week High
- NEU $637.35
- IONS $52.34
- Technical
- Relative Strength Index (RSI)
- NEU 72.65
- IONS 57.55
- Support Level
- NEU $618.86
- IONS $31.66
- Resistance Level
- NEU $638.01
- IONS $33.98
- Average True Range (ATR)
- NEU 12.56
- IONS 1.30
- MACD
- NEU 2.85
- IONS 0.41
- Stochastic Oscillator
- NEU 93.42
- IONS 68.84
About NEU NewMarket Corp
NewMarket Corp is a holding company that, through its subsidiaries, manufactures and sells petroleum additives. Petroleum additives are used in lubricating oils and fuels to enhance their performance in machinery, vehicles, and other equipment. It comprises two broad product applications. Lubricant additives are formulated chemical solutions that, when blended with base fluids, improve the efficiency, durability, performance, and functionality of mineral oils, synthetic oils, and biodegradable fluids. Fuel additives are chemical components that help oil refiners meet fuel specifications or formulated packages that improve the performance of gasoline, diesel, biofuels, and other fuels.
About IONS Ionis Pharmaceuticals Inc.
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and Biogen brought Spinraza to market in 2016 as a treatment for spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019). Ionis and AstraZeneca launched polyneuropathy drug Wainua in 2024. Ionis received FDA approval in 2024 for Tryngolza for a rare high-triglyceride syndrome, marking its first independent launch.